|

The following companies are currently located in the Boston University
Business Incubator.

BioMimetic Systems (BMS) is developing biologically
inspired technologies for advanced sensors and medical devices.
BMS has its roots in the Boston University Hearing Research Center
and VLSI laboratories with more than 30 years of experience researching
the physiology and biophysics of hearing as well as specialized
custom electronics. The focus of BMS is the application of biologically
inspired algorithms to technically challenging problems that traditional
approaches have failed to address. Applications include sensor design
for high noise environments as well as medical devices for the hearing
impaired. www.biomimetic-systems.com

Block MEMS is developing next generation
Fourier Transform Infrared (FTIR) spectrometers for chemical detection
in military, homeland security and industrial applications.
The optical sensors are the first to use microelectromechanical
(MEMS) technology to fabricate miniature spectrometers which are
portable (about the size of a pen), low cost and consume low power.
www.blockeng.com

Boston MicroFluidics (BMF) core product is a microfluidic
system capable of automating complex diagnostic chemistries and
reporting the outcome in a self contained consumable. Microfluidics,
tiny channels, valves and other elements, control the flow of microliters
of fluid in the testing system. In this way, extremely accurate
tests which have been restricted to remote laboratories due to their
complexity can be brought into the doctor's office. Tests
such as ELISA, an antibody based test that has been used to test
for sexually transmitted infections (STIs) for a quarter of a century,
can be automated using microfluidics. Automated, easy to use
testing systems like these are ideal for the fast paced point-of-care
facility. BMF's technology can be used to test for any of
the thousands of infections detectable by ELISA allowing the firm
to provide a number of diagnostic solutions. BMF's long-term
vision is to become the primary provider of disposable pathogen
detection devices in most major markets.
Cyber Materials (CM) develops advanced materials
process control technologies that improve manufacturing capability. CM's
product lines consist of operator level diagnostic tools and real-time
control solutions and have been applied to manufacturing optical
coatings, fuel cells, and thermal barrier coatings for gas turbines. CM delivers
value to its customers through reduced variation, improved capabilities,
higher yields, and increased productivity.

The DNA Repair Company (DNAR) is
utilizing breakthroughs in the knowledge about the major DNA repair
mechanisms to develop products that will improve cancer therapy
through personalized medicine.
The initial focus is on developing molecular diagnostic products
that use dynamic biomarkers to measure the functional status of
DNA damage repair pathways in individual tumors to guide optimal
cancer therapy. DNAR's development programs target both currently
marketed treatments (chemotherapy and radiation therapy), as
well as new drugs that are in development.

eQuilibrium Solution Corporation (eQ) offers the
first fully scalable, on-demand Enterprise Sustainability Management
(ESM) application suite — a web-deployed global solution for
sustainable, integrated management of environmentally critical policies,
processes, products and people.
This Business Process Management (BPM) solution is built on eQ's
five pillars of sustainability — Environmental Risk, Environmental
Governance, Environmental Compliance, Environmental Management Accounting
and Corporate Responsibility. Designed to serve corporations with
annual revenues in excess $1B, the eQ ESM Suite will empower leading
businesses to effectively balance their economic and environmental
responsibilities, creating a sustainable competitive advantage for
them and the communities to which they contribute.

lifeIMAGE, Inc. is an early-stage, Boston-based company designing a physician-to-physician professional network centered on clinical and diagnostic images. With lifeIMAGE, physicians anywhere in the world, can save, search for, and access relevant clinical images to help diagnose and treat patients and disease through collaboration, decision support, and education. lifeIMAGE is solving the conceptually simple, but technically complex task of capturing, storing, organizing, indexing, displaying, and most notably, sharing medical images. Physicians will use lifeIMAGE’s Web 2.0 functionality as a hosted personal PACS (Picture Archival & Communication System), and they can create or join private and public imaging forums for research, clinical trials, second opinions, telemedicine, or education.

LightKey has developed novel technology for wireless
and fiber optic communications that will enable network providers
to reduce operating expenses, lower capital expenditures and improve
service levels. This is achieved by employing advanced mathematical
techniques of time-frequency analysis to pre-compensate the carrier
waveform.
MTPV (Micro-gap Thermo Photo Voltaics) Corporation
is a clean energy company developing a revolutionary technology
for the conversion of thermal energy into electricity. By employing
a sub-micron gap between a thermal emitter and receiver, the achievable
power density can be increased by approximately an order of magnitude
as compared to conventional thermo-photo-voltaic devices. The technology
has been developed over the past ten years at MIT and Draper Laboratory.
The second generation technology, currently being perfected, will
provide an even larger scale and increase in performance allowing
more commercial opportunities to be achieved. www.mtpvcorp.com

PatentFlow Technology assists hospitals and other
healthcare organizations in managing patient flow issues by providing
consulting services and implementing software solutions. The
new technologies and services lead to reduced waiting times, reduced
operating costs and enhanced quality of care. www.patientflowtech.com

Sand 9 is a spin-out company from Boston
University developing revolutionary components for future generations
of ubiquitous wireless connectivity. Novel components based on nanoscale
silicon technology will enable enhanced wireless device performance
with reduced size and cost.
Successfully Launched Companies:

Progenika, a newly formed U.S. company, is a spin-out from Progenika Biopharma, S.A., a Spanish biotech company that designs and develops tools for personalized medicine. The company develops and manufactures novel DNA Genotyping microarrays for the diagnosis and prognosis of human disease. www.progenika.com

SOLX has developed a surgical laser and patented
method of treatment for glaucoma, the second most common cause of
blindness in the elderly. SOLX's DeepLight® Glaucoma Treatment
System is being developed to provide physicians with new tools to
reduce intraocular pressure in glaucoma sufferers through its DeepLight®
790 Titanium Sapphire Laser and DeepLight® Gold Micro-Shunt
(GMS(TM)). More information can be found online at www.SOLX.com
(corporate) and www.deeplightsystem.com
(healthcare professionals, patients and caregivers).
SOLX was acquired by Occulogix (NASDAQ: OCCX) in 2006. www.occulogix.com
|